Ezproz-D 40 Capsule PR
Marketer
Unilex Lifesciences Pvt Ltd
Salt Composition
Domperidone (30mg) + Esomeprazole (40mg)
Overview Ezproz-D 40 Capsule PR
Gastro-esophageal reflux disease (GERD) and indigestion, including symptoms like heartburn and stomach upset, are effectively managed with the prescription medication, Relifex-40 PR capsules. This medication neutralizes stomach acid and facilitates gas expulsion, alleviating discomfort. Relifex-40 PR capsules should be taken as directed by your physician, on an empty stomach, for the prescribed duration. Dosage is individualized based on your response and condition. Premature discontinuation may lead to symptom recurrence and worsening of the condition. Inform your doctor of all other medications you are using, as interactions are possible. Common, usually transient, side effects include diarrhea, flatulence, abdominal pain, dry mouth, and headache. Report any concerning side effects immediately. Drowsiness and dizziness are potential side effects; avoid driving or tasks demanding concentration until you assess your response. Alcohol consumption should be avoided due to potential increased drowsiness. Lifestyle adjustments, such as consuming cold milk and avoiding hot beverages, spicy foods, and chocolate, can enhance treatment outcomes. Before starting Relifex-40 PR, inform your doctor if you are pregnant, planning pregnancy, breastfeeding, or have liver disease to ensure appropriate dosage.
Uses of Ezproz-D 40 Capsule PR
Managing Gastroesophageal Reflux Disease (GERD)
Major Benefits of Ezproz-D 40 Capsule PR:
Follow your physician's instructions or consult the product label for usage guidance. Administer Ezproz-D 40 Capsule PR on an empty stomach.
Common Side effects of Ezproz-D 40 Capsule PR:
- Diarrhea
- Flatulence
- Stomach pain
- Dryness in mouth
- Headache
- Fundic gland polyps
How to use Ezproz-D 40 Capsule PR:
Follow your doctor's instructions or consult the product label for usage guidelines. Take Ezproz-D 40 Capsule PR on an empty stomach.
How Ezproz-D 40 Capsule PR works:
Ezproz-D 40 Capsule PR combines Domperidone and Esomeprazole to alleviate digestive issues. Domperidone, a prokinetic agent, enhances gastrointestinal motility, facilitating smoother food passage. Esomeprazole, a proton pump inhibitor (PPI), diminishes stomach acid production, providing relief from acid indigestion and heartburn.
SAFETY ADVICE
AlcoholCAUTION
Use of Ezproz-D 40 Capsule PR with alcohol requires careful consideration. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Ezproz-D 40 Capsule PR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any possible risks prior to prescription. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Nursing mothers can generally use Ezproz-D 40 Capsule PR without safety concerns. Research in humans indicates minimal drug transfer to breast milk, posing no apparent risk to the infant.
DrivingUNSAFE
Taking Ezproz-D 40 Capsule PR might cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Patients with kidney impairment should use Ezproz-D 40 Capsule PR cautiously, as dose modification may be necessary. Physician consultation is recommended.
LiverCAUTION
Patients with liver impairment should use Ezproz-D 40 Capsule PR cautiously, potentially requiring dosage modification. Physician consultation is advised. Ezproz-D 40 Capsule PR is contraindicated for individuals with moderate to severe hepatic dysfunction.
What if you forget to take Ezproz-D 40 Capsule PR :
Should you forget a dose of Ezproz-D 40 Capsule PR, administer it at your earliest convenience. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Ezproz-D 40 Capsule PR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |



